Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ARMSTRONG D., DRY R. M. L., KEELE C. A., MARKHAM J. W. Observations on chemical excitants of cutaneous pain in man. J Physiol. 1953 May 28;120(3):326–351. doi: 10.1113/jphysiol.1953.sp004898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ARMSTRONG D., JEPSON J. B., KEELE C. A., STEWART J. W. Pain-producing substance in human inflammatory exudates and plasma. J Physiol. 1957 Feb 15;135(2):350–370. doi: 10.1113/jphysiol.1957.sp005715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- AUSTEN K. F. The differentiation of the chloroform, peptone and antigen-antibody inducible esterase activities of human serum from plasmin. Immunology. 1960 Apr;3:152–173. [PMC free article] [PubMed] [Google Scholar]
- BERALDO W. T. Formation of bradykinin in anaphylactic and peptone shock. Am J Physiol. 1950 Nov;163(2):283–289. doi: 10.1152/ajplegacy.1950.163.2.283. [DOI] [PubMed] [Google Scholar]
- BHOOLA K. D., CALLE J. D., SCHACHTER M. The effect of bradykinin, serum kallikrein and other endogenous substances on capillary permeability inthe guinea-pig. J Physiol. 1960 Jun;152:75–86. doi: 10.1113/jphysiol.1960.sp006470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CRAWFORD T. B. B., OUTSCHOORN A. S. The quantitative separation of adrenaline and noradrenaline in biological fluids and tissue extracts. Br J Pharmacol Chemother. 1951 Mar;6(1):8–19. doi: 10.1111/j.1476-5381.1951.tb00614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GADDUM J. H., HORTON E. W. The extraction of human urinary kinin (substance Z) and its relation to the plasma kinins. Br J Pharmacol Chemother. 1959 Mar;14(1):117–124. doi: 10.1111/j.1476-5381.1959.tb00937.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HAMBERG U. Fibrinolytic activation and bradykinin release. Biochim Biophys Acta. 1959 Nov;36:296–298. doi: 10.1016/0006-3002(59)90115-5. [DOI] [PubMed] [Google Scholar]
- HORTON E. W. The estimation of urinary kallkrein. J Physiol. 1959 Oct;148:267–282. doi: 10.1113/jphysiol.1959.sp006287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LASSEN M. The esterase activity of the fibrinolytic system. Biochem J. 1958 Jul;69(3):360–366. doi: 10.1042/bj0690360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LEWIS G. P. Active polypeptides derived from plasma proteins. Physiol Rev. 1960 Oct;40:647–676. doi: 10.1152/physrev.1960.40.4.647. [DOI] [PubMed] [Google Scholar]
- LEWIS G. P. Formation of plasma kinins by plasmin. J Physiol. 1958 Feb 17;140(2):285–300. doi: 10.1113/jphysiol.1958.sp005934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MARGOLIS J. Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol. 1958 Nov 10;144(1):1–22. doi: 10.1113/jphysiol.1958.sp006082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MARGOLIS J. The mode of action of Hageman factor in the release of plasma kinin. J Physiol. 1960 May;151:238–252. doi: 10.1113/jphysiol.1960.sp006434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MILL P. J., ELDER J. M., MILES A. A., WILHELM D. L. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. VI. Isolation and properties of permeability factor and its inhibitor in human plasma. Br J Exp Pathol. 1958 Aug;39(4):343–355. [PMC free article] [PubMed] [Google Scholar]
- MULLERTZ S. Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochem J. 1955 Nov;61(3):424–434. doi: 10.1042/bj0610424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NORMAN P. S. Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma. J Exp Med. 1958 Jul 1;108(1):53–68. doi: 10.1084/jem.108.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RATNOFF O. D., DAVIE E. W., MALLETT D. L. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest. 1961 May;40:803–819. doi: 10.1172/JCI104314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RATNOFF O. D., ROSENBLUM J. M. Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. Am J Med. 1958 Aug;25(2):160–168. doi: 10.1016/0002-9343(58)90023-8. [DOI] [PubMed] [Google Scholar]
- TROLL W., SHERRY S. The activation of human plasminogen by streptokinase. J Biol Chem. 1955 Apr;213(2):881–891. [PubMed] [Google Scholar]
- VON KAULLA K. N., SCHULTZ R. L. Methods for the evaluation of human fibrinolysis; studies with two combined technics. Am J Clin Pathol. 1958 Feb;29(2):104–112. doi: 10.1093/ajcp/29.2.104. [DOI] [PubMed] [Google Scholar]
- WAALER B. A. Contact activation in the intrinsic blood clotting system; studies on a plasma product formed on contact with glass and similar surfaces. Scand J Clin Lab Invest. 1959;11(Suppl 37):1–133. [PubMed] [Google Scholar]
- WEBSTER M. E., ATNOFF O. D. Role of Hageman factor in the activation of vasodilator activity in human plasma. Nature. 1961 Oct 14;192:180–181. doi: 10.1038/192180a0. [DOI] [PubMed] [Google Scholar]
- WEBSTER M. E., PIERCE J. V. Studies on plasma kallikrein and its relationship to plasmin. J Pharmacol Exp Ther. 1960 Dec;130:484–491. [PubMed] [Google Scholar]
- WERLE E., MAIER L. Uber die chemische und pharmakologische Unterscheidung von Kallikreinen verschiedener Herkunft. Biochem Z. 1952;323(4):279–283. [PubMed] [Google Scholar]